PapersFlow Research Brief
Cardiovascular, Neuropeptides, and Oxidative Stress Research
Research Guide
What is Cardiovascular, Neuropeptides, and Oxidative Stress Research?
Cardiovascular, Neuropeptides, and Oxidative Stress Research is a field examining the role of Urotensin II in cardiovascular physiology and disease, including its vasoconstrictor activity, contributions to hypertension, atherosclerosis, endothelial dysfunction, renal function, smooth muscle cell proliferation, and interactions with the neuroendocrine system.
This research cluster contains 6,236 works focused on Urotensin II's effects in cardiovascular conditions. Key areas include vasoconstriction, hypertension, atherosclerosis, and endothelial dysfunction. Growth rate over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Urotensin II in Cardiovascular Disease
This sub-topic investigates Urotensin II's role in cardiac remodeling and heart failure. Researchers study its expression in human pathologies and therapeutic targeting.
Vasoconstrictor Activity of Urotensin II
This sub-topic examines Urotensin II receptor signaling in vascular tone regulation. Researchers compare its potency to endothelin in isolated arteries.
Urotensin II Receptor Antagonists
This sub-topic focuses on small-molecule and peptide inhibitors of the UT receptor. Researchers evaluate preclinical efficacy in hypertension models.
Urotensin II and Endothelial Dysfunction
This sub-topic explores Urotensin II's impairment of nitric oxide production in endothelium. Researchers link it to atherosclerosis progression.
Urotensin II in Renal Function
This sub-topic studies Urotensin II's effects on glomerular filtration and sodium handling. Researchers investigate its role in chronic kidney disease.
Why It Matters
Research in this field addresses cardiovascular diseases through Urotensin II's vasoconstrictor activity and links to hypertension and atherosclerosis, with potential for receptor antagonists to treat endothelial dysfunction and smooth muscle cell proliferation. For example, Rimm et al. (1993) found high vitamin E intake associated with lower coronary heart disease risk in men, highlighting oxidative stress mitigation relevant to Urotensin II pathways. Ambrose and Barua (2004) detailed how cigarette smoking promotes oxidative stress and endothelial damage, paralleling Urotensin II's role in vascular pathology. Berliner et al. (1995) showed oxidized LDL lipids in subendothelial space activate NF-κB, inducing genes that advance atherosclerosis, a process tied to Urotensin II-mediated dysfunction.
Reading Guide
Where to Start
"Vitamin E Consumption and the Risk of Coronary Heart Disease in Men" by Rimm et al. (1993) first, as it provides accessible evidence on oxidative stress reduction via antioxidants, foundational to understanding Urotensin II-related vascular protection.
Key Papers Explained
Gryglewski et al. (1986) established superoxide's role in breaking down relaxing factors, linking oxidative stress to endothelial dysfunction central to Urotensin II effects. Rimm et al. (1993) built on this by associating vitamin E intake with lower coronary risk, offering protective strategies. Ambrose and Barua (2004) connected smoking-induced oxidative damage to pathophysiology, while Berliner et al. (1995) detailed oxidized LDL's NF-κB activation in atherosclerosis, tying into Urotensin II vasoconstriction.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Focus persists on Urotensin II antagonists for hypertension and endothelial repair, with no recent preprints available. Emphasis remains on smooth muscle proliferation and renal links from established works.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Multifunctional Fish Gill: Dominant Site of Gas Exchange, ... | 2004 | Physiological Reviews | 2.8K | ✕ |
| 2 | Superoxide anion is involved in the breakdown of endothelium-d... | 1986 | Nature | 2.4K | ✕ |
| 3 | Vitamin E Consumption and the Risk of Coronary Heart Disease i... | 1993 | New England Journal of... | 2.4K | ✓ |
| 4 | The pathophysiology of cigarette smoking and cardiovascular di... | 2004 | Journal of the America... | 2.3K | ✕ |
| 5 | Role of transcription factor NF-kappa B/Rel in induction of ni... | 1994 | Journal of Biological ... | 2.2K | ✓ |
| 6 | Calcitonin gene-related peptide is a potent vasodilator | 1985 | Nature | 2.1K | ✕ |
| 7 | Endothelium‐derived relaxing and contracting factors | 1989 | The FASEB Journal | 2.0K | ✕ |
| 8 | Role of endothelium in responses of vascular smooth muscle. | 1983 | Circulation Research | 2.0K | ✕ |
| 9 | Deletion polymorphism in the gene for angiotensin-converting e... | 1992 | Nature | 1.9K | ✕ |
| 10 | Atherosclerosis: Basic Mechanisms | 1995 | Circulation | 1.7K | ✕ |
Latest Developments
Recent developments in cardiovascular, neuropeptides, and oxidative stress research include the exploration of next-generation antioxidants like setanaxib for cardiovascular disease (MDPI, 2026), the development of peptides such as NPA7 that inhibit cardiac oxidative stress by modulating specific pathways (American Heart Association, 2025), and the ongoing investigation into the signaling pathways of oxidative stress in the progression of cardiovascular diseases (NCBI, 2026). Additionally, recent studies highlight the role of neuropeptides like NPY in cardiovascular health and disease (Frontiers, 2018), and research continues to focus on the molecular mechanisms and potential therapeutic strategies targeting oxidative stress and related pathways (Nature, 2026; ABC Cardiol, 2026).
Sources
Frequently Asked Questions
What is the role of Urotensin II in cardiovascular disease?
Urotensin II acts as a vasoconstrictor contributing to hypertension, atherosclerosis, and endothelial dysfunction. It also influences smooth muscle cell proliferation and renal function. Receptor antagonists are under development to counter these effects.
How does oxidative stress relate to endothelial dysfunction in this research?
Oxidative stress from superoxide anion breaks down endothelium-derived relaxing factor, impairing vascular relaxation. Gryglewski et al. (1986) demonstrated this mechanism. It connects to Urotensin II's impact on endothelial function.
What applications do receptor antagonists have?
Receptor antagonists target Urotensin II to mitigate vasoconstriction, hypertension, and smooth muscle proliferation. They address cardiovascular and renal dysfunction. This stems from studies on Urotensin II physiology.
How does vitamin E factor into oxidative stress research here?
High vitamin E consumption links to reduced coronary heart disease risk in men. Rimm et al. (1993) reported this association from cohort data. It underscores antioxidant roles against oxidative damage in Urotensin II contexts.
What is the current state of this research field?
The field includes 6,236 works with no reported 5-year growth rate. Focus remains on Urotensin II's neuroendocrine and vascular roles. No recent preprints or news coverage noted.
Open Research Questions
- ? How do Urotensin II receptor antagonists specifically reduce smooth muscle cell proliferation in atherosclerosis models?
- ? What interactions occur between Urotensin II and oxidative stress pathways in renal dysfunction?
- ? To what extent does Urotensin II influence neuroendocrine regulation of hypertension?
- ? How does endothelial NF-κB activation by oxidized lipids intersect with Urotensin II signaling?
Recent Trends
The field holds steady at 6,236 works with no 5-year growth data.
No recent preprints or news in the last 12 months indicate stable focus on Urotensin II's vasoconstrictor roles, per keyword analysis.
Research Cardiovascular, Neuropeptides, and Oxidative Stress Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiovascular, Neuropeptides, and Oxidative Stress Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers